{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:17:27Z","timestamp":1791919047206,"version":"4.3.4"},"reference-count":291,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T00:00:00Z","timestamp":1640044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004744","name":"Innoviris","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004744","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Rare diseases are life-threatening or chronically debilitating low-prevalent disorders caused by pathogenic mutations or particular environmental insults. Due to their high complexity and low frequency, important gaps still exist in their prevention, diagnosis, and treatment. Since new drug discovery is a very costly and time-consuming process, leading pharmaceutical companies show relatively low interest in orphan drug research and development due to the high cost of investments compared to the low market return of the product. Drug repurposing\u2013based approaches appear then as cost- and time-saving strategies for the development of therapeutic opportunities for rare diseases. In this article, we discuss the scientific, regulatory, and economic aspects of the development of repurposed drugs for the treatment of rare neurodegenerative disorders with a particular focus on Huntington\u2019s disease, Friedreich\u2019s ataxia, Wolfram syndrome, and amyotrophic lateral sclerosis. The role of academia, pharmaceutical companies, patient associations, and foundations in the identification of candidate compounds and their preclinical and clinical evaluation will also be discussed.<\/jats:p>","DOI":"10.3389\/fphar.2021.768023","type":"journal-article","created":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T06:16:40Z","timestamp":1640067400000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":45,"title":["Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders"],"prefix":"10.3389","volume":"12","author":[{"given":"Sweta","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc Marie","family":"Dooms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Amaral-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Igoillo-Esteve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3109\/21678421.2014.959024","article-title":"Confirmatory Double-Blind, Parallel-Group, Placebo-Controlled Study of Efficacy and Safety of Edaravone (MCI-186) in Amyotrophic Lateral Sclerosis Patients","volume":"15","author":"Abe","year":"2014","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.145188","article-title":"A Phase 1b\/2a Clinical Trial of Dantrolene Sodium in Patients with Wolfram Syndrome","author":"Abreu","year":"2021","journal-title":"JCI Insight"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1162\/0033553041502144","article-title":"Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry","volume":"119","author":"Acemoglu","year":"2004","journal-title":"Q. J. Econ."},{"key":"B4","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1086\/303056","article-title":"Iron-dependent Self-Assembly of Recombinant Yeast Frataxin: Implications for Friedreich Ataxia","volume":"67","author":"Adamec","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/nsmb.1579","article-title":"Bacterial Frataxin CyaY Is the Gatekeeper of Iron-Sulfur Cluster Formation Catalyzed by IscS","volume":"16","author":"Adinolfi","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1093\/hmg\/11.16.1865","article-title":"A Structural Approach to Understanding the Iron-Binding Properties of Phylogenetically Different Frataxins","volume":"11","author":"Adinolfi","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nrneurol.2016.182","article-title":"Gene Discovery in Amyotrophic Lateral Sclerosis: Implications for Clinical Management","volume":"13","author":"Al-Chalabi","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/hmg\/ddm346","article-title":"The Friedreich Ataxia GAA Repeat Expansion Mutation Induces Comparable Epigenetic Changes in Human and Transgenic Mouse Brain and Heart Tissues","volume":"17","author":"Al-Mahdawi","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/mds.27604","article-title":"Drug Repositioning Screening Identifies Etravirine as a Potential Therapeutic for Friedreich's Ataxia","volume":"34","author":"Alfedi","year":"2019","journal-title":"Mov Disord."},{"key":"B10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2147\/DNND.S84956","article-title":"The Genetics of Amyotrophic Lateral Sclerosis: Current Insights","volume":"6","author":"Alsultan","year":"2016","journal-title":"Degener Neurol. Neuromuscul. Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/s0140-6736(74)92339-3","article-title":"Treatment of Huntington's Chorea with Lithium Carbonate. A Double-Blind Trial","volume":"1","author":"Aminoff","year":"1974","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1086\/520961","article-title":"A Homozygous Mutation in a Novel Zinc-finger Protein, ERIS, Is Responsible for Wolfram Syndrome 2","volume":"81","author":"Amr","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/s0140-6736(73)93285-6","article-title":"Baclofen and Lithium in Huntington's Chorea","volume":"2","author":"And\u00e9n","year":"1973","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.brainres.2011.01.058","article-title":"Feasibility Study for Functional Test Battery of SOD Transgenic Rat (H46R) and Evaluation of Edaravone, a Free Radical Scavenger","volume":"1382","author":"Aoki","year":"2011","journal-title":"Brain Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3233\/JHD-180312","article-title":"Cysteamine Protects Neurons from Mutant Huntingtin Toxicity","volume":"8","author":"Arbez","year":"2019","journal-title":"J. Huntingtons Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/0896-6273(95)90106-x","article-title":"CAG Expansion Affects the Expression of Mutant Huntingtin in the Huntington's Disease Brain","volume":"15","author":"Aronin","year":"1995","journal-title":"Neuron"},{"key":"B17","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug Repositioning: Identifying and Developing New Uses for Existing Drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1126\/science.276.5319.1709","article-title":"Regulation of Mitochondrial Iron Accumulation by Yfh1p, a Putative Homolog of Frataxin","volume":"276","author":"Babcock","year":"1997","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.neurobiolaging.2005.04.001","article-title":"The Protective Effects of Cystamine in the R6\/2 Huntington's Disease Mouse Involve Mechanisms Other Than the Inhibition of Tissue Transglutaminase","volume":"27","author":"Bailey","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1161\/CIRCULATIONAHA.107.739938","article-title":"Cardioprotective and Vasodilatory Actions of Glucagon-like Peptide 1 Receptor Are Mediated through Both Glucagon-like Peptide 1 Receptor-dependent and -independent Pathways","volume":"117","author":"Ban","year":"2008","journal-title":"Circulation"},{"key":"B21","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1093\/hmg\/ddu504","article-title":"Comparative Study of Naturally Occurring Huntingtin Fragments in Drosophila Points to Exon 1 as the Most Pathogenic Species in Huntington's Disease","volume":"24","author":"Barbaro","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/s0140-6736(95)92473-6","article-title":"Neurodegeneration and Diabetes: UK Nationwide Study of Wolfram (DIDMOAD) Syndrome","volume":"346","author":"Barrett","year":"1995","journal-title":"Lancet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s40618-020-01228-2","article-title":"Effect of 4-phenylbutyrate and Valproate on Dominant Mutations of WFS1 Gene in Wolfram Syndrome","volume":"43","author":"Batjargal","year":"2020","journal-title":"J. Endocrinol. Invest."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1182\/blood.v99.10.3813","article-title":"Erythroid Differentiation and Protoporphyrin IX Down-Regulate Frataxin Expression in Friend Cells: Characterization of Frataxin Expression Compared to Molecules Involved in Iron Metabolism and Hemoglobinization","volume":"99","author":"Becker","year":"2002","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e565","DOI":"10.1212\/WNL.0000000000004960","article-title":"Randomized, Double-Blind, Placebo-Controlled Trial of Arimoclomol in Rapidly Progressive SOD1 ALS","volume":"90","author":"Benatar","year":"2018","journal-title":"Neurology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s004150200071","article-title":"A Study of Riluzole in the Treatment of Advanced Stage or Elderly Patients with Amyotrophic Lateral Sclerosis","volume":"249","author":"Bensimon","year":"2002","journal-title":"J. Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis. ALS\/Riluzole Study Group","volume":"330","author":"Bensimon","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1093\/hmg\/10.22.2501","article-title":"Mutations in the Wolfram Syndrome 1 Gene (WFS1) Are a Common Cause of Low Frequency Sensorineural Hearing Loss","volume":"10","author":"Bespalova","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A Novel Pathogenic Pathway of Immune Activation Detectable before Clinical Onset in Huntington's Disease","volume":"205","author":"Bj\u00f6rkqvist","year":"2008","journal-title":"J. Exp. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1126\/science10.1126\/science.1169920","article-title":"Drug Discovery. Repurposing with a Difference","volume":"324","author":"Boguski","year":"2009","journal-title":"Science"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.2337\/db13-0571","article-title":"Autosomal Dominant Diabetes Arising from a Wolfram Syndrome 1 Mutation","volume":"62","author":"Bonnycastle","year":"2013","journal-title":"Diabetes"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1172\/JCI27607","article-title":"Cystamine and Cysteamine Increase Brain Levels of BDNF in Huntington Disease via HSJ1b and Transglutaminase","volume":"116","author":"Borrell-Pag\u00e8s","year":"2006","journal-title":"J. Clin. Invest."},{"key":"B33","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3389\/fphar.2019.00883","article-title":"Ambroxol Hydrochloride Improves Motor Functions and Extends Survival in a Mouse Model of Familial Amyotrophic Lateral Sclerosis","volume":"10","author":"Bouscary","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"173446","DOI":"10.1016\/j.ejphar.2020.173446","article-title":"Drug Repositioning in Neurodegeneration: An Overview of the Use of Ambroxol in Neurodegenerative Diseases","volume":"884","author":"Bouscary","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3109\/21678421.2012.750364","article-title":"Is Exposure to Cyanobacteria an Environmental Risk Factor for Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases?","volume":"14","author":"Bradley","year":"2013","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener"},{"key":"B36","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1111\/jcmm.13365","article-title":"Frataxin-deficient Neurons and Mice Models of Friedreich Ataxia Are Improved by TAT-MTScs-FXN Treatment","volume":"22","author":"Britti","year":"2018","journal-title":"J. Cel Mol Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1212\/01.wnl.0000068549.52812.0f","article-title":"Idebenone Treatment in Friedreich's Ataxia: Neurological, Cardiac, and Biochemical Monitoring","volume":"60","author":"Buyse","year":"2003","journal-title":"Neurology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e1002511","DOI":"10.1371\/journal.pbio.1002511","article-title":"Role of Mitochondrial Dynamics in Neuronal Development: Mechanism for Wolfram Syndrome","volume":"14","author":"Cagalinec","year":"2016","journal-title":"Plos Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.cmet.2013.04.008","article-title":"Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action","volume":"17","author":"Campbell","year":"2013","journal-title":"Cell Metab"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","article-title":"Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion","volume":"271","author":"Campuzano","year":"1996","journal-title":"Science"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18102092","article-title":"Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis","volume":"18","author":"Cappello","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nrd.2018.133","article-title":"Therapeutic Approaches to Huntington Disease: from the Bench to the Clinic","volume":"17","author":"Caron","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"B43","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/104990910502200112","article-title":"Modafinil to Treat Fatigue in Amyotrophic Lateral Sclerosis: an Open Label Pilot Study","volume":"22","author":"Carter","year":"2005","journal-title":"Am. J. Hosp. Palliat. Care"},{"key":"B44","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/bph.13798","article-title":"Drug Repurposing from the Perspective of Pharmaceutical Companies","volume":"175","author":"Cha","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1093\/hmg\/ddt115","article-title":"Heterochromatinization Induced by GAA-Repeat Hyperexpansion in Friedreich's Ataxia Can Be Reduced upon HDAC Inhibition by Vitamin B3","volume":"22","author":"Chan","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.4161\/auto.5.7.9351","article-title":"Cisd2 Mediates Mitochondrial Integrity and Life Span in Mammals","volume":"5","author":"Chen","year":"2009","journal-title":"Autophagy"},{"key":"B47","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/448645a","article-title":"New Uses for Old Drugs","volume":"448","author":"Chong","year":"2007","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1080\/14656566.2019.1639671","article-title":"New Developments in Pharmacotherapy for Friedreich Ataxia","volume":"20","author":"Clay","year":"2019","journal-title":"Expert Opin. Pharmacother."},{"key":"B49","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1002\/ana.23698","article-title":"Central Role and Mechanisms of \u03b2-cell Dysfunction and Death in Friedreich Ataxia-Associated Diabetes","volume":"72","author":"Cnop","year":"2012","journal-title":"Ann. Neurol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/jnc.12216","article-title":"Diabetes in Friedreich Ataxia","author":"Cnop","year":"2013","journal-title":"J. Neurochem."},{"key":"B51","volume-title":"Health and Food Safety Directorate-General, STAMP Unmet Medical Need - Revision of the Orphan and Paediatric Medicines Legislation","author":"Commission","year":"2021"},{"key":"B52","volume-title":"Pharmaceutical Strategy for Europe 2020","author":"Commission","year":"2020"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1093\/hmg\/ddp592","article-title":"Molecular Control of the Cytosolic aconitase\/IRP1 Switch by Extramitochondrial Frataxin","volume":"19","author":"Cond\u00f2","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"B54","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/ane.13088","article-title":"Patient-reported Outcomes in Friedreich's Ataxia after Withdrawal from Idebenone","volume":"139","author":"Cook","year":"2019","journal-title":"Acta Neurol. Scand."},{"key":"B55","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/humu.10258","article-title":"Mutational Spectrum of the WFS1 Gene in Wolfram Syndrome, Nonsyndromic Hearing Impairment, Diabetes Mellitus, and Psychiatric Disease","volume":"22","author":"Cryns","year":"2003","journal-title":"Hum. Mutat."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1001\/jama.2015.10214","article-title":"Effect of Dextromethorphan-Quinidine on Agitation in Patients with Alzheimer Disease Dementia: A Randomized Clinical Trial","volume":"314","author":"Cummings","year":"2015","journal-title":"JAMA"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.2337\/db09-0685","article-title":"Glucagon-like Peptide-1 Agonists Protect Pancreatic Beta-Cells from Lipotoxic Endoplasmic Reticulum Stress through Upregulation of BiP and JunB","volume":"58","author":"Cunha","year":"2009","journal-title":"Diabetes"},{"key":"B58","doi-asserted-by":"publisher","first-page":"7853","DOI":"10.3390\/ijms14047853","article-title":"Frataxin Deficiency Leads to Reduced Expression and Impaired Translocation of NF-E2-Related Factor (Nrf2) in Cultured Motor Neurons","volume":"14","author":"D'oria","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/s0140-6736(73)90510-2","article-title":"Lithium Therapy in Huntington's Chorea and Tardive Dyskinesia","volume":"1","author":"Dal\u00e9n","year":"1973","journal-title":"Lancet"},{"key":"B60","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1210\/jc.2016-2240","article-title":"GLP-1-RA Corrects Mitochondrial Labile Iron Accumulation and Improves \u03b2-Cell Function in Type 2 Wolfram Syndrome","volume":"101","author":"Danielpur","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B61","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/0019-5545.105522","article-title":"Off Label Use of Lithium in the Treatment of Huntington's Disease: A Case Series","volume":"55","author":"Danivas","year":"2013","journal-title":"Indian J. Psychiatry"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.2337\/db16-1296","article-title":"Dominant ER Stress-Inducing WFS1 Mutations Underlie a Genetic Syndrome of Neonatal\/Infancy-Onset Diabetes, Congenital Sensorineural Deafness, and Congenital Cataracts","volume":"66","author":"De Franco","year":"2017","journal-title":"Diabetes"},{"key":"B63","doi-asserted-by":"publisher","first-page":"8942","DOI":"10.1523\/jneurosci.22-20-08942.2002","article-title":"Therapeutic Effects of Cystamine in a Murine Model of Huntington's Disease","volume":"22","author":"Dedeoglu","year":"2002","journal-title":"J. Neurosci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain","volume":"277","author":"Difiglia","year":"1997","journal-title":"Science"},{"key":"B65","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","article-title":"Innovation in the Pharmaceutical Industry: New Estimates of R&D Costs","volume":"47","author":"Dimasi","year":"2016","journal-title":"J. Health Econ."},{"key":"B66","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1111\/febs.14379","article-title":"The Role of Nrf2 Signaling in Counteracting Neurodegenerative Diseases","volume":"285","author":"Dinkova-Kostova","year":"2018","journal-title":"FEBS J."},{"key":"B67","doi-asserted-by":"publisher","first-page":"8100","DOI":"10.1073\/pnas.1508767112","article-title":"Glycosphingolipids Are Modulators of Disease Pathogenesis in Amyotrophic Lateral Sclerosis","volume":"112","author":"Dodge","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B68","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cel Metab"},{"key":"B69","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1073\/pnas.84.10.3434","article-title":"Glucagon-like Peptide I Stimulates Insulin Gene Expression and Increases Cyclic AMP Levels in a Rat Islet Cell Line","volume":"84","author":"Drucker","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B70","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1159\/000069318","article-title":"Effect of a Novel Free Radical Scavenger, Edaravone (MCI-186), on Acute Brain Infarction. Randomized, Placebo-Controlled, Double-Blind Study at Multicenters","volume":"15","author":"Edaravone Acute Infarction Study","year":"2003","journal-title":"Cerebrovasc. Dis."},{"key":"B71","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1136\/jmg.2005.034892","article-title":"Autosomal Dominant Optic Atrophy Associated with Hearing Impairment and Impaired Glucose Regulation Caused by a Missense Mutation in the WFS1 Gene","volume":"43","author":"Eiberg","year":"2006","journal-title":"J. Med. Genet."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1086\/302858","article-title":"Homozygosity Mapping Identifies an Additional Locus for Wolfram Syndrome on Chromosome 4q","volume":"66","author":"El-Shanti","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1212\/WNL.0b013e31828f18ac","article-title":"Cognitive Changes Predict Functional Decline in ALS: a Population-Based Longitudinal Study","volume":"80","author":"Elamin","year":"2013","journal-title":"Neurology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1212\/wnl.55.11.1752","article-title":"Increased Levels of Plasma Malondialdehyde in Friedreich Ataxia","volume":"55","author":"Emond","year":"2000","journal-title":"Neurology"},{"key":"B75","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ymgme.2011.10.009","article-title":"Initial Experience in the Treatment of Inherited Mitochondrial Disease with EPI-743","volume":"105","author":"Enns","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"B76","doi-asserted-by":"publisher","first-page":"404","DOI":"10.2174\/0929867324666170718101946","article-title":"NGS Technologies as a Turning Point in Rare Disease Research , Diagnosis and Treatment","volume":"25","author":"Fernandez-Marmiesse","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"B77","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.therap.2020.02.006","article-title":"Drug Repurposing in Rare Diseases: Myths and Reality","volume":"75","author":"Fetro","year":"2020","journal-title":"Therapie"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1212\/wnl.38.8.1292","article-title":"Glucose Metabolism Alterations in Friedreich's Ataxia","volume":"38","author":"Finocchiaro","year":"1988","journal-title":"Neurology"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1038\/s41591-019-0676-z","article-title":"Benefit Corporation: a Path to Affordable Gene Therapies?","volume":"25","author":"Fischer","year":"2019","journal-title":"Nat. Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cophys.2020.07.009","article-title":"Wolfram Syndrome: a Monogenic Model to Study Diabetes Mellitus and Neurodegeneration","volume":"17","author":"Fischer","year":"2020","journal-title":"Curr. Opin. Physiol."},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-021-01064-z","article-title":"Drug Repurposing: A Network-Based Approach to Amyotrophic Lateral Sclerosis","author":"Fiscon","year":"2021","journal-title":"Neurotherapeutics"},{"key":"B82","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.coph.2009.07.003","article-title":"Endoplasmic Reticulum Stress in Beta-Cells and Development of Diabetes","volume":"9","author":"Fonseca","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"39609","DOI":"10.1074\/jbc.M507426200","article-title":"WFS1 Is a Novel Component of the Unfolded Protein Response and Maintains Homeostasis of the Endoplasmic Reticulum in Pancreatic Beta-Cells","volume":"280","author":"Fonseca","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B84","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.tem.2011.02.008","article-title":"Endoplasmic Reticulum Stress and Pancreatic \u03b2-cell Death","volume":"22","author":"Fonseca","year":"2011","journal-title":"Trends Endocrinol. Metab."},{"key":"B85","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1172\/JCI39678","article-title":"Wolfram Syndrome 1 Gene Negatively Regulates ER Stress Signaling in Rodent and Human Cells","volume":"120","author":"Fonseca","year":"2010","journal-title":"J. Clin. Invest."},{"key":"B86","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/WNF.0b013e3180ca77ea","article-title":"A Study of Chorea after Tetrabenazine Withdrawal in Patients with Huntington Disease","volume":"31","author":"Frank","year":"2008","journal-title":"Clin. Neuropharmacol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1471-2377-9-62","article-title":"Tetrabenazine as Anti-chorea Therapy in Huntington Disease: an Open-Label Continuation Study. Huntington Study Group\/TETRA-HD Investigators","volume":"9","author":"Frank","year":"2009","journal-title":"BMC Neurol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s13311-013-0244-z","article-title":"Treatment of Huntington's Disease","volume":"11","author":"Frank","year":"2014","journal-title":"Neurotherapeutics"},{"key":"B89","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/jmg.14.3.190","article-title":"Diabetes Mellitus, Diabetes Insipidus, and Optic Atrophy. An Autosomal Recessive Syndrome?","volume":"14","author":"Fraser","year":"1977","journal-title":"J. Med. Genet."},{"key":"B90","doi-asserted-by":"publisher","first-page":"26965","DOI":"10.1074\/jbc.272.43.26965","article-title":"Dantrolene Inhibition of Sarcoplasmic Reticulum Ca2+ Release by Direct and Specific Action at Skeletal Muscle Ryanodine Receptors","volume":"272","author":"Fruen","year":"1997","journal-title":"J. Biol. Chem."},{"key":"B91","doi-asserted-by":"publisher","first-page":"31652","DOI":"10.1038\/srep31652","article-title":"Laquinimod Rescues Striatal, Cortical and white Matter Pathology and Results in Modest Behavioural Improvements in the YAC128 Model of Huntington Disease","volume":"6","author":"Garcia-Miralles","year":"2016","journal-title":"Sci. Rep."},{"key":"B92","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/sj.embor.embor918","article-title":"An Interaction between Frataxin and Isu1\/Nfs1 that Is Crucial for Fe\/S Cluster Synthesis on Isu1","volume":"4","author":"Gerber","year":"2003","journal-title":"EMBO Rep."},{"key":"B93","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/hmg\/dds400","article-title":"Vacuolar-type H+-ATPase V1A Subunit Is a Molecular Partner of Wolfram Syndrome 1 (WFS1) Protein, Which Regulates its Expression and Stability","volume":"22","author":"Gharanei","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-71779-1_1","article-title":"Clinical Features of Huntington's Disease","volume":"1049","author":"Ghosh","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1006\/mgme.2000.3107","article-title":"Presence of a Major WFS1 Mutation in Spanish Wolfram Syndrome Pedigrees","volume":"72","author":"G\u00f3mez-Zaera","year":"2001","journal-title":"Mol. Genet. Metab."},{"key":"B96","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2165\/00019053-200422002-00003","article-title":"Are the Economics of Pharmaceutical Research and Development Changing? Productivity, Patents and Political Pressures","volume":"22","author":"Grabowski","year":"2004","journal-title":"Pharmacoeconomics"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1002\/acn3.51098","article-title":"Spreading in ALS: The Relative Impact of Upper and Lower Motor Neuron Involvement","volume":"7","author":"Gromicho","year":"2020","journal-title":"Ann. Clin. Transl Neurol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1006\/exnr.1998.6919","article-title":"Regional Specificity of Brain Atrophy in Huntington's Disease","volume":"154","author":"Halliday","year":"1998","journal-title":"Exp. Neurol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/sj.ejhg.5201491","article-title":"Mutation Analysis of the WFS1 Gene in Seven Danish Wolfram Syndrome Families; Four New Mutations Identified","volume":"13","author":"Hansen","year":"2005","journal-title":"Eur. J. Hum. Genet."},{"key":"B100","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","article-title":"Amyotrophic Lateral Sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B101","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/brain\/104.3.589","article-title":"Friedreich's Ataxia: a Clinical and Genetic Study of 90 Families with an Analysis of Early Diagnostic Criteria and Intrafamilial Clustering of Clinical Features","volume":"104","author":"Harding","year":"1981","journal-title":"Brain"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1086\/302609","article-title":"Clinical and Molecular Genetic Analysis of 19 Wolfram Syndrome Kindreds Demonstrating a Wide Spectrum of Mutations in WFS1","volume":"65","author":"Hardy","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"B103","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/s0006-291x(03)01254-3","article-title":"Bimoclomol, a Heat Shock Protein Co-inducer, Acts by the Prolonged Activation of Heat Shock Factor-1","volume":"307","author":"Hargitai","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1093\/hmg\/ddq568","article-title":"Wolfram Syndrome 1 Gene (WFS1) Product Localizes to Secretory Granules and Determines Granule Acidification in Pancreatic Beta-Cells","volume":"20","author":"Hatanaka","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"B105","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1136\/heart.87.4.346","article-title":"Idebenone and Reduced Cardiac Hypertrophy in Friedreich's Ataxia","volume":"87","author":"Hausse","year":"2002","journal-title":"Heart"},{"key":"B106","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3389\/fnmol.2017.00433","article-title":"Sphingolipid Metabolism Is Dysregulated at Transcriptomic and Metabolic Levels in the Spinal Cord of an Animal Model of Amyotrophic Lateral Sclerosis","volume":"10","author":"Henriques","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"B107","doi-asserted-by":"publisher","first-page":"7390","DOI":"10.1093\/hmg\/ddv439","article-title":"Amyotrophic Lateral Sclerosis and Denervation Alter Sphingolipids and Up-Regulate Glucosylceramide Synthase","volume":"24","author":"Henriques","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"B108","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nchembio815","article-title":"Histone Deacetylase Inhibitors Reverse Gene Silencing in Friedreich's Ataxia","volume":"2","author":"Herman","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2337\/db15-0443","article-title":"Topical Administration of GLP-1 Receptor Agonists Prevents Retinal Neurodegeneration in Experimental Diabetes","volume":"65","author":"Hern\u00e1ndez","year":"2016","journal-title":"Diabetes"},{"key":"B110","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1007\/s00125-017-4388-y","article-title":"Topical Administration of DPP-IV Inhibitors Prevents Retinal Neurodegeneration in Experimental Diabetes","volume":"60","author":"Hern\u00e1ndez","year":"2017","journal-title":"Diabetologia"},{"key":"B111","first-page":"26","article-title":"Autosomal Dominant Optic Neuropathy and Sensorineual Hearing Loss Associated with a Novel Mutation of WFS1","volume":"16","author":"Hogewind","year":"2010","journal-title":"Mol. Vis."},{"key":"B112","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1185\/03007995.2010.549466","article-title":"Neuroprotective Properties of GLP-1: Theoretical and Practical Applications","volume":"27","author":"Holst","year":"2011","journal-title":"Curr. Med. Res. Opin."},{"key":"B113","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1242\/jcs.178293","article-title":"Activation of Apoptosis in NAF-1-Deficient Human Epithelial Breast Cancer Cells","volume":"129","author":"Holt","year":"2016","journal-title":"J. Cel Sci"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s40265-019-01162-5","article-title":"Onasemnogene Abeparvovec: First Global Approval","volume":"79","author":"Hoy","year":"2019","journal-title":"Drugs"},{"key":"B115","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2202-13-33","article-title":"Drugs Developed to Treat Diabetes, Liraglutide and Lixisenatide, Cross the Blood Brain Barrier and Enhance Neurogenesis","volume":"13","author":"Hunter","year":"2012","journal-title":"BMC Neurosci."},{"key":"B116","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1001\/jama.2016.8655","article-title":"Effect of Deutetrabenazine on Chorea Among Patients with Huntington Disease: A Randomized Clinical Trial","volume":"316","author":"Huntington Study","year":"2016","journal-title":"JAMA"},{"key":"B117","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1212\/01.wnl.0000198586.85250.13","article-title":"Tetrabenazine as Antichorea Therapy in Huntington Disease: a Randomized Controlled Trial","volume":"66","author":"Huntington Study","year":"2006","journal-title":"Neurology"},{"key":"B118","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1093\/hmg\/ddu745","article-title":"Unveiling a Common Mechanism of Apoptosis in \u03b2-cells and Neurons in Friedreich's Ataxia","volume":"24","author":"Igoillo-Esteve","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.134221","article-title":"Exenatide Induces Frataxin Expression and Improves Mitochondrial Function in Friedreich Ataxia","volume":"5","author":"Igoillo-Esteve","year":"2020","journal-title":"JCI Insight"},{"key":"B120","doi-asserted-by":"publisher","first-page":"e033131","DOI":"10.1136\/bmjopen-2019-033131","article-title":"Induced Pluripotent Stem Cell-Based Drug Repurposing for Amyotrophic Lateral Sclerosis Medicine (iDReAM) Study: Protocol for a Phase I Dose Escalation Study of Bosutinib for Amyotrophic Lateral Sclerosis Patients","volume":"9","author":"Imamura","year":"2019","journal-title":"BMJ Open"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf3962","article-title":"The Src\/c-Abl Pathway Is a Potential Therapeutic Target in Amyotrophic Lateral Sclerosis","volume":"9","author":"Imamura","year":"2017","journal-title":"Sci. Transl Med."},{"key":"B122","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/2441","article-title":"A Gene Encoding a Transmembrane Protein Is Mutated in Patients with Diabetes Mellitus and Optic Atrophy (Wolfram Syndrome)","volume":"20","author":"Inoue","year":"1998","journal-title":"Nat. Genet."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1093\/hmg\/ddh125","article-title":"Disruption of the WFS1 Gene in Mice Causes Progressive Beta-Cell Loss and Impaired Stimulus-Secretion Coupling in Insulin Secretion","volume":"13","author":"Ishihara","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"B124","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.neulet.2010.08.005","article-title":"Modanifil Activates the Histaminergic System through the Orexinergic Neurons","volume":"483","author":"Ishizuka","year":"2010","journal-title":"Neurosci. Lett."},{"key":"B125","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.expneurol.2008.07.017","article-title":"Treatment with Edaravone, Initiated at Symptom Onset, Slows Motor Decline and Decreases SOD1 Deposition in ALS Mice","volume":"213","author":"Ito","year":"2008","journal-title":"Exp. Neurol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1586\/ern.11.149","article-title":"Tetrabenazine for the Treatment of Chorea and Other Hyperkinetic Movement Disorders","volume":"11","author":"Jankovic","year":"2011","journal-title":"Expert Rev. Neurother"},{"key":"B127","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1093\/hmg\/11.24.3055","article-title":"A Cellular Model for Friedreich Ataxia Reveals Small-Molecule Glutathione Peroxidase Mimetics as Novel Treatment Strategy","volume":"11","author":"Jauslin","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"B128","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13023-018-0990-4","article-title":"Estimating the Clinical Cost of Drug Development for Orphan versus Non-orphan Drugs","volume":"14","author":"Jayasundara","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"B129","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1527-3458.2003.tb00249.x","article-title":"Valproate: Past, Present, and Future","volume":"9","author":"Johannessen","year":"2003","journal-title":"CNS Drug Rev."},{"key":"B130","doi-asserted-by":"publisher","first-page":"e0214250","DOI":"10.1371\/journal.pone.0214250","article-title":"Targeting Ferroptosis: A Novel Therapeutic Strategy for the Treatment of Mitochondrial Disease-Related Epilepsy","volume":"14","author":"Kahn-Kirby","year":"2019","journal-title":"PLoS One"},{"key":"B131","doi-asserted-by":"publisher","first-page":"e4134","DOI":"10.1371\/journal.pone.0004134","article-title":"Valproate, a Mood Stabilizer, Induces WFS1 Expression and Modulates its Interaction with ER Stress Protein GRP94","volume":"4","author":"Kakiuchi","year":"2009","journal-title":"PLoS One"},{"key":"B132","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1042\/BST0330551","article-title":"Molecular Chaperones as Therapeutic Targets in Amyotrophic Lateral Sclerosis","volume":"33","author":"Kalmar","year":"2005","journal-title":"Biochem. Soc. Trans."},{"key":"B133","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pharmthera.2013.08.003","article-title":"The Role of Heat Shock Proteins in Amyotrophic Lateral Sclerosis: The Therapeutic Potential of Arimoclomol","volume":"141","author":"Kalmar","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"B134","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/j.1471-4159.2008.05595.x","article-title":"Late Stage Treatment with Arimoclomol Delays Disease Progression and Prevents Protein Aggregation in the SOD1 Mouse Model of ALS","volume":"107","author":"Kalmar","year":"2008","journal-title":"J. Neurochem."},{"key":"B135","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/s0197-0186(01)00060-2","article-title":"Evidence for a Role for Transglutaminase in Huntington's Disease and the Potential Therapeutic Implications","volume":"40","author":"Karpuj","year":"2002","journal-title":"Neurochem. Int."},{"key":"B136","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13023-018-0936-x","article-title":"From Scientific Discovery to Treatments for Rare Diseases - the View from the National Center for Advancing Translational Sciences - Office of Rare Diseases Research","volume":"13","author":"Kaufmann","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"B137","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1377\/hlthaff.2014.1038","article-title":"The Roles of Academia, Rare Diseases, and Repurposing in the Development of the Most Transformative Drugs","volume":"34","author":"Kesselheim","year":"2015","journal-title":"Health Aff. (Millwood)"},{"key":"B138","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/humu.1110","article-title":"WFS1\/wolframin Mutations, Wolfram Syndrome, and Associated Diseases","volume":"17","author":"Khanim","year":"2001","journal-title":"Hum. Mutat."},{"key":"B139","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nm1021","article-title":"Treatment with Arimoclomol, a Coinducer of Heat Shock Proteins, Delays Disease Progression in ALS Mice","volume":"10","author":"Kieran","year":"2004","journal-title":"Nat. Med."},{"key":"B140","doi-asserted-by":"publisher","first-page":"18399","DOI":"10.1074\/jbc.M100103200","article-title":"Hemin-induced Activation of the Thioredoxin Gene by Nrf2. A Differential Regulation of the Antioxidant Responsive Element by a Switch of its Binding Factors","volume":"276","author":"Kim","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.2337\/diacare.18.12.1566","article-title":"Morbidity and Mortality in the Wolfram Syndrome","volume":"18","author":"Kinsley","year":"1995","journal-title":"Diabetes Care"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2011.01.010","article-title":"Friedreich's Ataxia: Pathology, Pathogenesis, and Molecular Genetics","volume":"303","author":"Koeppen","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"B143","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00401-007-0220-y","article-title":"The Dentate Nucleus in Friedreich's Ataxia: the Role of Iron-Responsive Proteins","volume":"114","author":"Koeppen","year":"2007","journal-title":"Acta Neuropathol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40478-016-0288-5","article-title":"Dorsal Root Ganglia in Friedreich Ataxia: Satellite Cell Proliferation and Inflammation","volume":"4","author":"Koeppen","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"B145","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1007\/s00125-018-4679-y","article-title":"Activation of GLP-1 Receptor Signalling Alleviates Cellular Stresses and Improves Beta Cell Function in a Mouse Model of Wolfram Syndrome","volume":"61","author":"Kondo","year":"2018","journal-title":"Diabetologia"},{"key":"B146","doi-asserted-by":"publisher","first-page":"499","DOI":"10.4149\/gpb_2020017","article-title":"Lack of Functional Wolframin Causes Drop in Plasmalemmal Sodium-Calcium Exchanger Type 1 Expression at Early Stage in Rat Model of Wolfram Syndrome","volume":"39","author":"Kurekov\u00e1","year":"2020","journal-title":"Gen. Physiol. Biophys."},{"key":"B147","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/j.1749-6632.2002.tb04306.x","article-title":"Effect of BRX-220 against Peripheral Neuropathy and Insulin Resistance in Diabetic Rat Models","volume":"967","author":"K\u00fcrthy","year":"2002","journal-title":"Ann. N. Y Acad. Sci."},{"key":"B148","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.tibs.2013.05.003","article-title":"Huntington's Disease: Underlying Molecular Mechanisms and Emerging Concepts","volume":"38","author":"Labbadia","year":"2013","journal-title":"Trends Biochem. Sci."},{"key":"B149","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/s0140-6736(96)91680-3","article-title":"Dose-ranging Study of Riluzole in Amyotrophic Lateral Sclerosis. Amyotrophic Lateral Sclerosis\/Riluzole Study Group II","volume":"347","author":"Lacomblez","year":"","journal-title":"Lancet"},{"key":"B150","doi-asserted-by":"publisher","first-page":"S242","DOI":"10.1212\/wnl.47.6_suppl_4.242s","article-title":"A Confirmatory Dose-Ranging Study of Riluzole in ALS. ALS\/Riluzole Study Group-II","volume":"47","author":"Lacomblez","year":"","journal-title":"Neurology"},{"key":"B151","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ahj.2010.10.038","article-title":"Idebenone in Friedreich Ataxia Cardiomyopathy-Results from a 6-month Phase III Study (IONIA)","volume":"161","author":"Lagedrost","year":"2011","journal-title":"Am. Heart J."},{"key":"B152","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1038\/ncomms3753","article-title":"Soluble Forms of polyQ-Expanded Huntingtin rather Than Large Aggregates Cause Endoplasmic Reticulum Stress","volume":"4","author":"Leitman","year":"2013","journal-title":"Nat. Commun."},{"key":"B153","doi-asserted-by":"publisher","first-page":"e55940","DOI":"10.1371\/journal.pone.0055940","article-title":"Pharmacological Screening Using an FXN-EGFP Cellular Genomic Reporter Assay for the Therapy of Friedreich Ataxia","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"B154","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/S0140-6736(14)60382-2","article-title":"Epigenetic and Neurological Effects and Safety of High-Dose Nicotinamide in Patients with Friedreich's Ataxia: an Exploratory, Open-Label, Dose-Escalation Study","volume":"384","author":"Libri","year":"2014","journal-title":"Lancet"},{"key":"B155","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/ana.410120308","article-title":"Tetrabenazine Has Properties of a Dopamine Receptor Antagonist","volume":"12","author":"Login","year":"1982","journal-title":"Ann. Neurol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1136\/jnnp.2009.183525","article-title":"Incidence of Amyotrophic Lateral Sclerosis in Europe","volume":"81","author":"Logroscino","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B157","doi-asserted-by":"publisher","first-page":"E5292","DOI":"10.1073\/pnas.1421055111","article-title":"A Calcium-dependent Protease as a Potential Therapeutic Target for Wolfram Syndrome","volume":"111","author":"Lu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B158","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/ana.25934","article-title":"Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study)","volume":"89","author":"Lynch","year":"2021","journal-title":"Ann. Neurol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/acn3.660","article-title":"Safety, Pharmacodynamics, and Potential Benefit of Omaveloxolone in Friedreich Ataxia","volume":"6","author":"Lynch","year":"","journal-title":"Ann. Clin. Transl Neurol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/acn3.731","article-title":"Randomized, Double-Blind, Placebo-Controlled Study of Interferon-\u03b3 1b in Friedreich Ataxia","volume":"6","author":"Lynch","year":"","journal-title":"Ann. Clin. Transl Neurol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1001\/archneurol.2010.168","article-title":"A Phase 3, Double-Blind, Placebo-Controlled Trial of Idebenone in Friedreich Ataxia","volume":"67","author":"Lynch","year":"2010","journal-title":"Arch. Neurol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s40265-016-0574-3","article-title":"Idebenone: A Review in Leber's Hereditary Optic Neuropathy","volume":"76","author":"Lyseng-Williamson","year":"2016","journal-title":"Drugs"},{"key":"B163","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1212\/01.wnl.0000055872.50364.fc","article-title":"Idebenone Treatment in Friedreich Patients: One-Year-Long Randomized Placebo-Controlled Trial","volume":"60","author":"Mariotti","year":"2003","journal-title":"Neurology"},{"key":"B164","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.brainresrev.2011.04.001","article-title":"Friedreich's Ataxia: Past, Present and Future","volume":"67","author":"Marmolino","year":"2011","journal-title":"Brain Res. Rev."},{"key":"B165","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1750-1172-8-64","article-title":"Phenotypic Characteristics of Early Wolfram Syndrome","volume":"8","author":"Marshall","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"B166","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nn.2528","article-title":"Cargo Recognition Failure Is Responsible for Inefficient Autophagy in Huntington's Disease","volume":"13","author":"Martinez-Vicente","year":"2010","journal-title":"Nat. Neurosci."},{"key":"B167","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/978-3-319-67144-4_25","article-title":"Rare Neurodegenerative Diseases: Clinical and Genetic Update","volume":"1031","author":"Matilla-Due\u00f1as","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/s0140-6736(73)91500-610.1016\/s0140-6736(73)92529-4","article-title":"Huntington's Chorea, Lithium, and G.A.B.A","volume":"2","author":"Mattsson","year":"1973","journal-title":"Lancet"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax9106","article-title":"Gene-edited Human Stem Cell-Derived \u03b2 Cells from a Patient with Monogenic Diabetes Reverse Preexisting Diabetes in Mice","volume":"12","author":"Maxwell","year":"2020","journal-title":"Sci. Transl Med."},{"key":"B170","doi-asserted-by":"publisher","first-page":"6587","DOI":"10.1523\/JNEUROSCI.0529-11.2011","article-title":"The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease","volume":"31","author":"Mcclean","year":"2011","journal-title":"J. Neurosci."},{"key":"B171","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington's Disease: a Clinical Review","volume":"25","author":"Mccolgan","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/jnnp.68.5.661","article-title":"Frataxin point Mutations in Two Patients with Friedreich's Ataxia and Unusual Clinical Features","volume":"68","author":"Mccormack","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B173","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s00415-011-6174-y","article-title":"Assessment of Neurological Efficacy of Idebenone in Pediatric Patients with Friedreich's Ataxia: Data from a 6-month Controlled Study Followed by a 12-month Open-Label Extension Study","volume":"259","author":"Meier","year":"2012","journal-title":"J. Neurol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3389\/fnins.2019.01310","article-title":"ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?","volume":"13","author":"Mejzini","year":"2019","journal-title":"Front. Neurosci."},{"key":"B175","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13023-016-0445-8","article-title":"The Partnership of Patient Advocacy Groups and Clinical Investigators in the Rare Diseases Clinical Research Network","volume":"11","author":"Merkel","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"B176","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3233\/BEN-2012-120268","article-title":"The Role of Dopamine and Glutamate Modulation in Huntington Disease","volume":"26","author":"Mittal","year":"2013","journal-title":"Behav. Neurol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nrd.2016.96","article-title":"Regulatory Watch: The Orphan Drug Pipeline in Europe","volume":"15","author":"Morel","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"B178","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1471-2350-15-88","article-title":"A Novel CISD2 Intragenic Deletion, Optic Neuropathy and Platelet Aggregation Defect in Wolfram Syndrome Type 2","volume":"15","author":"Mozzillo","year":"2014","journal-title":"BMC Med. Genet."},{"key":"B179","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/B978-0-12-801893-4.00001-8","article-title":"Genetics of Huntington Disease","volume":"144","author":"Nance","year":"2017","journal-title":"Handb Clin. Neurol."},{"key":"B180","first-page":"57","article-title":"Therapeutic Drug Repurposing, Repositioning and Rescue, Part II: Business Review","volume":"16","author":"Naylor","year":"2015","journal-title":"Drug Discov. World"},{"key":"B181","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41431-019-0508-0","article-title":"Estimating Cumulative point Prevalence of Rare Diseases: Analysis of the Orphanet Database","volume":"28","author":"Nguengang Wakap","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"key":"B182","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10238-006-0099-2","article-title":"Ambroxol for the Prevention of Acute Upper Respiratory Disease","volume":"6","author":"Nobata","year":"2006","journal-title":"Clin. Exp. Med."},{"key":"B183","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/534314a","article-title":"Can You Teach Old Drugs New Tricks?","volume":"534","author":"Nosengo","year":"2016","journal-title":"Nature"},{"key":"B184","doi-asserted-by":"publisher","first-page":"e10818","DOI":"10.7759\/cureus.10818","article-title":"Post-marketing Experience of Edaravone in Amyotrophic Lateral Sclerosis: A Clinical Perspective and Comparison with the Clinical Trials of the Drug","volume":"12","author":"Ortiz","year":"2020","journal-title":"Cureus"},{"key":"B185","doi-asserted-by":"publisher","first-page":"eaat5847","DOI":"10.1126\/sciadv.aat5847","article-title":"Microphysiological 3D Model of Amyotrophic Lateral Sclerosis (ALS) from Human iPS-Derived Muscle Cells and Optogenetic Motor Neurons","volume":"4","author":"Osaki","year":"2018","journal-title":"Sci. Adv."},{"key":"B186","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.cmet.2012.07.005","article-title":"Thioredoxin-interacting Protein Mediates ER Stress-Induced \u03b2 Cell Death through Initiation of the Inflammasome","volume":"16","author":"Oslowski","year":"2012","journal-title":"Cel Metab"},{"key":"B187","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3233\/JPD-160867","article-title":"Nilotinib Effects in Parkinson's Disease and Dementia with Lewy Bodies","volume":"6","author":"Pagan","year":"2016","journal-title":"J. Parkinsons Dis."},{"key":"B188","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1001\/jamaneurol.2019.4200","article-title":"Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial","volume":"77","author":"Pagan","year":"2020","journal-title":"JAMA Neurol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/mds.28389","article-title":"Long-Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease","volume":"36","author":"Pagan","year":"2021","journal-title":"Mov Disord."},{"key":"B190","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/ana.24248","article-title":"Deferiprone in Friedreich Ataxia: a 6-month Randomized Controlled Trial","volume":"76","author":"Pandolfo","year":"2014","journal-title":"Ann. Neurol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00415-009-1002-3","article-title":"Friedreich Ataxia: the Clinical Picture","author":"Pandolfo","year":"2009","journal-title":"J. Neurol."},{"key":"B192","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/jnc.12300","article-title":"Deferiprone for the Treatment of Friedreich's Ataxia","author":"Pandolfo","year":"2013","journal-title":"J. Neurochem."},{"key":"B193","doi-asserted-by":"publisher","first-page":"59","DOI":"10.12793\/tcp.2019.27.2.59","article-title":"A Review of Computational Drug Repurposing","volume":"27","author":"Park","year":"2019","journal-title":"Transl Clin. Pharmacol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/jnc.12317","article-title":"Clinical Features of Friedreich's Ataxia: Classical and Atypical Phenotypes","author":"Parkinson","year":"2013","journal-title":"J. Neurochem."},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.97152","article-title":"Neuroleptics as Therapeutic Compounds Stabilizing Neuromuscular Transmission in Amyotrophic Lateral Sclerosis","volume":"2","author":"Patten","year":"2017","journal-title":"JCI Insight"},{"key":"B196","doi-asserted-by":"publisher","first-page":"e4253","DOI":"10.1371\/journal.pone.0004253","article-title":"Impaired Nuclear Nrf2 Translocation Undermines the Oxidative Stress Response in Friedreich Ataxia","volume":"4","author":"Paupe","year":"2009","journal-title":"PLoS One"},{"key":"B197","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1177\/0883073812448535","article-title":"Cardiomyopathy in Friedreich Ataxia: Clinical Findings and Research","volume":"27","author":"Payne","year":"2012","journal-title":"J. Child. Neurol."},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20205211","article-title":"Targeting NRF2 for the Treatment of Friedreich's Ataxia: A Comparison Among Drugs","volume":"20","author":"Petrillo","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18102173","article-title":"Nrf2-Inducers Counteract Neurodegeneration in Frataxin-Silenced Motor Neurons: Disclosing New Therapeutic Targets for Friedreich's Ataxia","volume":"18","author":"Petrillo","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B200","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/jnnp-2011-300188","article-title":"The Syndrome of Cognitive Impairment in Amyotrophic Lateral Sclerosis: a Population-Based Study","volume":"83","author":"Phukan","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B201","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.drudis.2017.11.002","article-title":"Rare Genetic Diseases: Update on Diagnosis, Treatment and Online Resources","volume":"23","author":"Pogue","year":"2018","journal-title":"Drug Discov. Today"},{"key":"B202","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/ijo.2012.91","article-title":"Liraglutide Improves Hippocampal Synaptic Plasticity Associated with Increased Expression of Mash1 in Ob\/ob Mice","volume":"37","author":"Porter","year":"2013","journal-title":"Int. J. Obes. (Lond)"},{"key":"B203","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s13311-018-0634-3","article-title":"Chronic Administration of Pimozide Fails to Attenuate Motor and Pathological Deficits in Two Mouse Models of Amyotrophic Lateral Sclerosis","volume":"15","author":"Pozzi","year":"2018","journal-title":"Neurotherapeutics"},{"key":"B204","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/84818","article-title":"Mouse Models for Friedreich Ataxia Exhibit Cardiomyopathy, Sensory Nerve Defect and Fe-S Enzyme Deficiency Followed by Intramitochondrial Iron Deposits","volume":"27","author":"Puccio","year":"2001","journal-title":"Nat. Genet."},{"key":"B205","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug Repurposing: Progress, Challenges and Recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"B206","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/mus.21245","article-title":"Modafinil Treatment of Fatigue in Patients with ALS: a Placebo-Controlled Study","volume":"39","author":"Rabkin","year":"2009","journal-title":"Muscle Nerve"},{"key":"B207","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11211-019-00332-w","article-title":"(In)-Equality in the Allocation of R&D Resources for Rare Diseases","volume":"32","author":"Ra\u00efs Ali","year":"2019","journal-title":"Soc. Just Res."},{"key":"B208","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1097\/JCP.0b013e31829c9748","article-title":"Lithium Treatment in Patients with Huntington Disease and Suicidal Behavior","volume":"33","author":"Raja","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"key":"B209","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000314720","article-title":"Is Prevalence of Retinopathy Related to the Age of Onset of Diabetes? Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Report No. 5","volume":"45","author":"Raman","year":"2011","journal-title":"Ophthalmic Res."},{"key":"B210","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1212\/wnl.42.6.1220","article-title":"Wolfram Syndrome: Evidence of a Diffuse Neurodegenerative Disease by Magnetic Resonance Imaging","volume":"42","author":"Rando","year":"1992","journal-title":"Neurology"},{"key":"B211","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/hmg\/11.9.1107","article-title":"Aggregate-prone Proteins with Polyglutamine and Polyalanine Expansions Are Degraded by Autophagy","volume":"11","author":"Ravikumar","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"B212","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR Induces Autophagy and Reduces Toxicity of Polyglutamine Expansions in Fly and Mouse Models of Huntington Disease","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nat. Genet."},{"key":"B213","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1212\/01.wnl.0000261045.57095.56","article-title":"Implications of ALS Focality: Rostral-Caudal Distribution of Lower Motor Neuron Loss Postmortem","volume":"68","author":"Ravits","year":"","journal-title":"Neurology"},{"key":"B214","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1212\/01.wnl.0000260965.20021.47","article-title":"Focality of Upper and Lower Motor Neuron Degeneration at the Clinical Onset of ALS","volume":"68","author":"Ravits","year":"","journal-title":"Neurology"},{"key":"B215","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrd.2015.19","article-title":"Towards a Hit for Every Target","volume":"15","author":"Rees","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"B216","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.drudis.2015.12.008","article-title":"Open Innovation in Early Drug Discovery: Roadmaps and Roadblocks","volume":"21","author":"Reichman","year":"2016","journal-title":"Drug Discov. Today"},{"key":"B217","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nn.3584","article-title":"State of Play in Amyotrophic Lateral Sclerosis Genetics","volume":"17","author":"Renton","year":"2014","journal-title":"Nat. Neurosci."},{"key":"B218","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1007\/s00125-005-1947-4","article-title":"Mice Conditionally Lacking the Wolfram Gene in Pancreatic Islet Beta Cells Exhibit Diabetes as a Result of Enhanced Endoplasmic Reticulum Stress and Apoptosis","volume":"48","author":"Riggs","year":"2005","journal-title":"Diabetologia"},{"key":"B219","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/MOP.0b013e328354ccdf","article-title":"Wolfram Syndrome 1 and Wolfram Syndrome 2","volume":"24","author":"Rigoli","year":"2012","journal-title":"Curr. Opin. Pediatr."},{"key":"B220","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1007\/s00415-009-5130-6","article-title":"Low-dose Idebenone Treatment in Friedreich's Ataxia with and without Cardiac Hypertrophy","volume":"256","author":"Rinaldi","year":"2009","journal-title":"J. Neurol."},{"key":"B221","doi-asserted-by":"publisher","first-page":"105162","DOI":"10.1016\/j.nbd.2020.105162","article-title":"PPAR Gamma Agonist Leriglitazone Improves Frataxin-Loss Impairments in Cellular and Animal Models of Friedreich Ataxia","volume":"148","author":"Rodr\u00edguez-Pascau","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"B222","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00592-014-0648-1","article-title":"Wolfram Syndrome 2: a Novel CISD2 Mutation Identified in Italian Siblings","volume":"52","author":"Rondinelli","year":"2015","journal-title":"Acta Diabetol."},{"key":"B223","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1007\/s00018-007-7079-x","article-title":"The Mechanisms of Action of Valproate in Neuropsychiatric Disorders: Can We See the forest for the Trees?","volume":"64","author":"Rosenberg","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"B224","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nrm1742","article-title":"Opinion: What Is the Role of Protein Aggregation in Neurodegeneration?","volume":"6","author":"Ross","year":"2005","journal-title":"Nat. Rev. Mol. Cel Biol"},{"key":"B225","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/ng1097-215","article-title":"Aconitase and Mitochondrial Iron-sulphur Protein Deficiency in Friedreich Ataxia","volume":"17","author":"R\u00f6tig","year":"1997","journal-title":"Nat. Genet."},{"key":"B226","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","article-title":"Amyotrophic Lateral Sclerosis","volume":"344","author":"Rowland","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"B227","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1212\/wnl.62.3.524","article-title":"Idebenone Treatment in Friedreich Patients: One-Year-Long Randomized Placebo-Controlled Trial","volume":"62","author":"Rustin","year":"2004","journal-title":"Neurology"},{"key":"B228","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0140-6736(99)01341-0","article-title":"Effect of Idebenone on Cardiomyopathy in Friedreich's Ataxia: a Preliminary Study","volume":"354","author":"Rustin","year":"1999","journal-title":"Lancet"},{"key":"B229","doi-asserted-by":"publisher","first-page":"6848","DOI":"10.1093\/hmg\/ddu408","article-title":"Dyclonine Rescues Frataxin Deficiency in Animal Models and Buccal Cells of Patients with Friedreich's Ataxia","volume":"23","author":"Sahdeo","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B230","doi-asserted-by":"publisher","first-page":"5641","DOI":"10.1074\/jbc.M609532200","article-title":"Trehalose, a Novel mTOR-independent Autophagy Enhancer, Accelerates the Clearance of Mutant Huntingtin and Alpha-Synuclein","volume":"282","author":"Sarkar","year":"","journal-title":"J. Biol. Chem."},{"key":"B231","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1083\/jcb.200504035","article-title":"Lithium Induces Autophagy by Inhibiting Inositol Monophosphatase","volume":"170","author":"Sarkar","year":"2005","journal-title":"J. Cel Biol"},{"key":"B232","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nchembio883","article-title":"Small Molecules Enhance Autophagy and Reduce Toxicity in Huntington's Disease Models","volume":"3","author":"Sarkar","year":"","journal-title":"Nat. Chem. Biol."},{"key":"B233","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/s0092-8674(00)81782-1","article-title":"Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions","volume":"95","author":"Saudou","year":"1998","journal-title":"Cell"},{"key":"B234","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/nature01596","article-title":"DNA Triplet Repeats Mediate Heterochromatin-Protein-1-Sensitive Variegated Gene Silencing","volume":"422","author":"Saveliev","year":"2003","journal-title":"Nature"},{"key":"B235","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.7150\/ijbs.9898","article-title":"Preclinical and Clinical Investigations of Mood Stabilizers for Huntington's Disease: what Have We Learned?","volume":"10","author":"Scheuing","year":"2014","journal-title":"Int. J. Biol. Sci."},{"key":"B236","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/BF00277262","article-title":"Preclinical and Manifest Diabetes Mellitus in Young Patients with Friedreich's Ataxia: No Evidence of Immune Process behind the Islet Cell Destruction","volume":"32","author":"Schoenle","year":"1989","journal-title":"Diabetologia"},{"key":"B237","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1212\/wnl.55.11.1719","article-title":"Oxidative Stress in Patients with Friedreich Ataxia","volume":"55","author":"Schulz","year":"2000","journal-title":"Neurology"},{"key":"B238","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00018-015-2052-6","article-title":"The Endoplasmic Reticulum: Structure, Function and Response to Cellular Signaling","volume":"73","author":"Schwarz","year":"2016","journal-title":"Cel Mol Life Sci"},{"key":"B239","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000510852","article-title":"Efficacy of GLP-1 Agonist Therapy in Autosomal Dominant WFS1-Related Disorder: A Case Report","volume":"93","author":"Scully","year":"2020","journal-title":"Horm. Res. Paediatr."},{"key":"B240","doi-asserted-by":"publisher","first-page":"9239530","DOI":"10.1155\/2016\/9239530","article-title":"Exenatide Is an Effective Antihyperglycaemic Agent in a Mouse Model of Wolfram Syndrome 1","volume":"2016","author":"Sedman","year":"2016","journal-title":"J. Diabetes Res."},{"key":"B241","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.neubiorev.2017.08.006","article-title":"Cerebral Abnormalities in Friedreich Ataxia: A Review","volume":"84","author":"Selvadurai","year":"2018","journal-title":"Neurosci. Biobehav Rev."},{"key":"B242","doi-asserted-by":"publisher","first-page":"15742","DOI":"10.1038\/s41598-019-52295-2","article-title":"GLP-1 Receptor Agonist Liraglutide Has a Neuroprotective Effect on an Aged Rat Model of Wolfram Syndrome","volume":"9","author":"Seppa","year":"2019","journal-title":"Sci. Rep."},{"key":"B243","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/ane.12337","article-title":"Open-label Pilot Study of Interferon Gamma-1b in Friedreich Ataxia","volume":"132","author":"Seyer","year":"2015","journal-title":"Acta Neurol. Scand."},{"key":"B244","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/hmg\/ddh114","article-title":"Idebenone Delays the Onset of Cardiac Functional Alteration without Correction of Fe-S Enzymes Deficit in a Mouse Model for Friedreich Ataxia","volume":"13","author":"Seznec","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"B245","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1089\/ars.2012.4537","article-title":"Frataxin Deficiency Leads to Defects in Expression of Antioxidants and Nrf2 Expression in Dorsal Root Ganglia of the Friedreich's Ataxia YG8R Mouse Model","volume":"19","author":"Shan","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"B246","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1542\/peds.79.6.1032","article-title":"Pimozide Treatment of Tic and Tourette Disorders","volume":"79","author":"Shapiro","year":"1987","journal-title":"Pediatrics"},{"key":"B247","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1038\/s41467-019-09494-2","article-title":"Felodipine Induces Autophagy in Mouse Brains with Pharmacokinetics Amenable to Repurposing","volume":"10","author":"Siddiqi","year":"2019","journal-title":"Nat. Commun."},{"key":"B248","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1093\/hmg\/ddv096","article-title":"Expanded GAA Repeats Impair FXN Gene Expression and Reposition the FXN Locus to the Nuclear Lamina in Single Cells","volume":"24","author":"Silva","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"B249","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/nrd4202","article-title":"Opening the lead Generation Toolbox","volume":"13","author":"Simpson","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"B250","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4155\/tde.10.12","article-title":"Realizing the Potential of Therapeutic Stem Cells with Effective Delivery","volume":"1","author":"Sleigh","year":"","journal-title":"Ther. Deliv."},{"key":"B251","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/BF03256811","article-title":"Repurposing Strategies for Therapeutics","volume":"24","author":"Sleigh","year":"","journal-title":"Pharm. Med."},{"key":"B252","doi-asserted-by":"publisher","first-page":"11402","DOI":"10.1073\/pnas.0503634102","article-title":"Absence of Behavioral Abnormalities and Neurodegeneration In Vivo Despite Widespread Neuronal Huntingtin Inclusions","volume":"102","author":"Slow","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B253","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective Striatal Neuronal Loss in a YAC128 Mouse Model of Huntington Disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"B254","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ng0893-393","article-title":"Relationship between Trinucleotide Repeat Expansion and Phenotypic Variation in Huntington's Disease","volume":"4","author":"Snell","year":"1993","journal-title":"Nat. Genet."},{"key":"B255","doi-asserted-by":"publisher","first-page":"14676","DOI":"10.1073\/pnas.1313198110","article-title":"NAF-1 and mitoNEET Are central to Human Breast Cancer Proliferation by Maintaining Mitochondrial Homeostasis and Promoting Tumor Growth","volume":"110","author":"Sohn","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B256","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1080\/21678707.2016.1215910","article-title":"Translating HDAC Inhibitors in Friedreich's Ataxia","volume":"4","author":"Soragni","year":"2016","journal-title":"Expert Opin. Orphan Drugs"},{"key":"B257","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/ana.24260","article-title":"Epigenetic Therapy for Friedreich Ataxia","volume":"76","author":"Soragni","year":"2014","journal-title":"Ann. Neurol."},{"key":"B258","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1056\/NEJMsa1008268","article-title":"The Role of Public-Sector Research in the Discovery of Drugs and Vaccines","volume":"364","author":"Stevens","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B259","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/jnr.23508","article-title":"Wfs1-deficient Animals Have Brain-region-specific Changes of Na+, K+-ATPase Activity and mRNA Expression of \u03b11 and \u03b21 Subunits","volume":"93","author":"S\u00fctt","year":"2015","journal-title":"J. Neurosci. Res."},{"key":"B260","first-page":"821","article-title":"Assessment of the Efficacy of Treatment with Pimozide in Patients with Amyotrophic Lateral Sclerosis. Introductory Notes","volume":"32","author":"Szczudlik","year":"1998","journal-title":"Neurol. Neurochir Pol."},{"key":"B261","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/21678421.2017.1361443","article-title":"Post-hoc Analysis of Randomised, Placebo-Controlled, Double-Blind Study (MCI186-19) of Edaravone (MCI-186) in Amyotrophic Lateral Sclerosis","volume":"18","author":"Takei","year":"2017","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener"},{"key":"B262","doi-asserted-by":"publisher","first-page":"10183","DOI":"10.1038\/s41598-018-28314-z","article-title":"Preventive Treatment with Liraglutide Protects against Development of Glucose Intolerance in a Rat Model of Wolfram Syndrome","volume":"8","author":"Toots","year":"2018","journal-title":"Sci. Rep."},{"key":"B263","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/ng0595-104","article-title":"Cellular Localization of the Huntington's Disease Protein and Discrimination of the normal and Mutated Form","volume":"10","author":"Trottier","year":"1995","journal-title":"Nat. Genet."},{"key":"B264","doi-asserted-by":"publisher","first-page":"9132","DOI":"10.1021\/bi1013062","article-title":"Human Frataxin Is an Allosteric Switch that Activates the Fe-S Cluster Biosynthetic Complex","volume":"49","author":"Tsai","year":"2010","journal-title":"Biochemistry"},{"key":"B265","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/14737175.2016.1226134","article-title":"Antipsychotic Drugs in Huntington's Disease","volume":"17","author":"Unti","year":"2017","journal-title":"Expert Rev. Neurother"},{"key":"B266","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11892-015-0702-6","article-title":"Wolfram Syndrome: Diagnosis, Management, and Treatment","volume":"16","author":"Urano","year":"2016","journal-title":"Curr. Diab Rep."},{"key":"B267","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1471-4159.2005.03357.x","article-title":"Cystamine Treatment Is Neuroprotective in the YAC128 Mouse Model of Huntington Disease","volume":"95","author":"Van Raamsdonk","year":"2005","journal-title":"J. Neurochem."},{"key":"B268","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/jnc.12215","article-title":"Prevalence Gradients of Friedreich's Ataxia and R1b Haplotype in Europe Co-localize, Suggesting a Common Palaeolithic Origin in the Franco-Cantabrian Ice Age Refuge","author":"Vankan","year":"2013","journal-title":"J. Neurochem."},{"key":"B269","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3389\/fphar.2019.01664","article-title":"On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients","volume":"10","author":"Verbaanderd","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B270","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/mds.27010","article-title":"A Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Cysteamine in Huntington's Disease","volume":"32","author":"Verny","year":"2017","journal-title":"Mov Disord."},{"key":"B271","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/nm1097-1150","article-title":"Bimoclomol: a Nontoxic, Hydroxylamine Derivative with Stress Protein-Inducing Activity and Cytoprotective Effects","volume":"3","author":"V\u00edgh","year":"1997","journal-title":"Nat. Med."},{"key":"B272","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2165\/00063030-200822040-00004","article-title":"Long-acting GLP-1 Analogs for the Treatment of Type 2 Diabetes Mellitus","volume":"22","author":"Vilsb\u00f8ll","year":"2008","journal-title":"BioDrugs"},{"key":"B273","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3109\/10715762.2014.936431","article-title":"Cisd2 Mediates Lifespan: Is There an Interconnection Among Ca\u00b2\u207a Homeostasis, Autophagy, and Lifespan?","volume":"48","author":"Wang","year":"2014","journal-title":"Free Radic. Res."},{"key":"B274","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neuro.2016.06.015","article-title":"Identification of Risk Factors Associated with Onset and Progression of Amyotrophic Lateral Sclerosis Using Systematic Review and Meta-Analysis","volume":"61","author":"Wang","year":"2017","journal-title":"Neurotoxicology"},{"key":"B275","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2796.2006.01666.x","article-title":"A Journey of hope: Lessons Learned from Studies on Rare Diseases and Orphan Drugs","volume":"260","author":"W\u00e4stfelt","year":"2006","journal-title":"J. Intern. Med."},{"key":"B276","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2217\/nmt.15.52","article-title":"IFN-\u03b3 for Friedreich Ataxia: Present Evidence","volume":"5","author":"Wells","year":"2015","journal-title":"Neurodegener Dis. Manag."},{"key":"B277","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/emmm.201201429","article-title":"Wolfram Syndrome Protein, Miner1, Regulates Sulphydryl Redox Status, the Unfolded Protein Response, and Ca2+ Homeostasis","volume":"5","author":"Wiley","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"B278","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nchembio.79","article-title":"Novel Targets for Huntington's Disease in an mTOR-independent Autophagy Pathway","volume":"4","author":"Williams","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"B279","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2020.1166","article-title":"Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018","volume":"323","author":"Wouters","year":"2020","journal-title":"JAMA"},{"key":"B280","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S1474-4422(17)30115-1","article-title":"Safety and Efficacy of Edaravone in Well Defined Patients with Amyotrophic Lateral Sclerosis: a Randomised, Double-Blind, Placebo-Controlled Trial","volume":"16","author":"Writing","year":"2017","journal-title":"Lancet Neurol."},{"key":"B281","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1093\/hmg\/ddl081","article-title":"WFS1-deficiency Increases Endoplasmic Reticulum Stress, Impairs Cell Cycle Progression and Triggers the Apoptotic Pathway Specifically in Pancreatic Beta-Cells","volume":"15","author":"Yamada","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"B282","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 Guidelines for the Management of Patients with Bipolar Disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord."},{"key":"B283","doi-asserted-by":"publisher","first-page":"25943","DOI":"10.1074\/jbc.C400107200","article-title":"Frataxin-mediated Iron Delivery to Ferrochelatase in the Final Step of Heme Biosynthesis","volume":"279","author":"Yoon","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B284","doi-asserted-by":"publisher","first-page":"6078","DOI":"10.1021\/ja027967i","article-title":"Iron-sulfur Cluster Biosynthesis. Characterization of Frataxin as an Iron Donor for Assembly of [2Fe-2S] Clusters in ISU-type Proteins","volume":"125","author":"Yoon","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"B285","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/17482960600881870","article-title":"Investigation of the Therapeutic Effects of Edaravone, a Free Radical Scavenger, on Amyotrophic Lateral Sclerosis (Phase II Study)","volume":"7","author":"Yoshino","year":"2006","journal-title":"Amyotroph. Lateral Scler."},{"key":"B286","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.cmet.2006.10.001","article-title":"GLP-1 Receptor Activation Improves Beta Cell Function and Survival Following Induction of Endoplasmic Reticulum Stress","volume":"4","author":"Yusta","year":"2006","journal-title":"Cel Metab"},{"key":"B287","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1093\/hmg\/ddu499","article-title":"Sarco(endo)plasmic Reticulum ATPase Is a Molecular Partner of Wolfram Syndrome 1 Protein, Which Negatively Regulates its Expression","volume":"24","author":"Zatyka","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"B288","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1093\/hmg\/ddm296","article-title":"Sodium-potassium ATPase 1 Subunit Is a Molecular Partner of Wolframin, an Endoplasmic Reticulum Protein Involved in ER Stress","volume":"17","author":"Zatyka","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"B289","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1016\/j.jmb.2020.02.012","article-title":"Autophagy in Rare (NonLysosomal) Neurodegenerative Diseases","volume":"432","author":"Zatyka","year":"2020","journal-title":"J. Mol. Biol."},{"key":"B290","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2217\/nmt-2018-0013","article-title":"Double-blind, Randomized and Controlled Trial of EPI-743 in Friedreich's Ataxia","volume":"8","author":"Zesiewicz","year":"2018","journal-title":"Neurodegener Dis. Manag."},{"key":"B291","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.npep.2018.07.003","article-title":"Neuroprotective Effects of the Novel GLP-1 Long Acting Analogue Semaglutide in the MPTP Parkinson's Disease Mouse Model","volume":"71","author":"Zhang","year":"2018","journal-title":"Neuropeptides"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.768023\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T06:16:56Z","timestamp":1640067416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.768023\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,21]]},"references-count":291,"alternative-id":["10.3389\/fphar.2021.768023"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.768023","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,21]]},"article-number":"768023"}}